Skip to main content
Funded Studies

Ming-Ming Zhou, PhD

Lamport Professor and Chairman of the Department of Structural and Chemical Biology, and Professor of Oncological Sciences at Mount Sinai School of Medicine

Location: New York, NY United States

Dr. Ming-Ming Zhou is an internationally recognized expert in NMR spectroscopy of protein structure-function and structure-based small-molecule design. He received his PhD degree in Chemistry from Purdue University in 1993 and performed postdoctoral study at Abbott Laboratories before joining Mount Sinai School of Medicine as a faculty member in 1997. His research interests are directed at (1) structure and mechanisms of epigenetic gene regulation and histone-directed chromatin biology; (2) structure-based small molecule design; and (3) mechanism-based disease biology and drug discovery in HIV/AIDS, cancers, Alzheimer’s and Parkinson’s disease.

Dr. Zhou's contributions in his area of research include structure-guided functional discovery of the conserved bromodomain as an acetyl-lysine binding domain (Nature 1999), and the PAZ domain as a conserved RNA binding domain (Nature 2003), both of which have broad implications in epigenetic chromatin biology and RNA interference. His work in rational design of chemical probes for mechanism-driven research is demonstrated by his discovery of the HIV Tat/human co-activator PCAF interaction as a potential novel anti-HIV therapy target (Mol. Cell 2002; JACS 2005), for which he received the Glaxo/Smith Kline Drug Discovery & Development Award in 2003. Recently, Dr. Zhou has developed novel small-molecule probes that modulate the transcriptional activity of human tumor suppressor p53 in DNA damage repair (Chem. & Biol. 2006).

Associated Grants

  • Structural and Chemical Approaches to Understand and Modulate LRRK2 Kinase Activity in Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.